article thumbnail

New Eli Lilly Eczema Drug Brings Competition and Dosing Edge Versus Sanofi, LEO Pharma Meds

MedCity News

billion acquisition of Dermira in 2020. The post New Eli Lilly Eczema Drug Brings Competition and Dosing Edge Versus Sanofi, LEO Pharma Meds appeared first on MedCity News. Eli Lilly drug Ebglyss is now FDA-approved for atopic dermatitis, an inflammatory skin disorder also known as eczema. The biologic drug came from Lilly’s $1.1

article thumbnail

2020 Sales Hiring Forecast

Sales Talent

By comparing these forecasts to historical data, we developed our 2020 sales hiring forecast. 2020 Sales Hiring Forecast. Sales hiring in 2020 shows no signs of slowing down. Manpower forecasts a Q1 2020 Net Employment Outlook for the U.S. 4 percent in 2020. 2019 Sales Hiring in Review. YOY increase.

Sales 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Competition is on the horizon for costly narcolepsy treatments

pharmaphorum

But increased competition is on the horizon. In 2020, and in an attempt to abate the drawback, Jazz got FDA approval for Xywav, which is a mixture of calcium, magnesium, and potassium salts that contains 92% less sodium than Xyrem. Competition starts to heat up. Classic treatment options. Xyrem is one of three that has a patent.

article thumbnail

The Top 10 Medical Device Success Podcasts in 2020!

Medical Device Success

35 podcasts were produced in our inaugural year of 2020. 1 Ep 4 – The Future of the Medical Device Industry in the Covid-19 Era, April 12, 2020. 2 Ep 6 – Selling in a Covid-19 Word – New Sales Practices, April 26, 2020. 3 Ep 10 – The Reopening, Covid-19 and what it means for Medical Devices, May 24, 2020.

Medical 100
article thumbnail

The perfect storm is coming for pharma

World of DTC Marketing

Retail price increases for widely used brand name prescription drugs consistently exceeded the rate of general inflation between 2006 and 2020. In 2020, retail prices for 260 brand-name prescription drugs widely used by older adults increased by an average of 2.9 In contrast, the general inflation rate was 1.3

Pharma 187
article thumbnail

Innovation key for boosting UK biopharma competitiveness

European Pharmaceutical Review

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. The ‘Sectoral Systems of Innovation and the UK’s Competitiveness’ reports assess the value-added per capita of each sector and how they compare internationally.

article thumbnail

Selling with Certainty in Uncertain Times

Integrity Solutions

Getting new deals and creating lifelong clients is where you can find growth in challenged, unstable markets, even as your competition flounders. We saw this play out during the Covid pandemic in 2020.

Sales 130